“The HighWire” host Del Bigtree, slammed the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) and the World Health Organization (WHO) for concealing the fact that Wuhan coronavirus (COVID-19) vaccines cause Guillain-Barre Syndrome (GBS).
GBS happens when a person’s own immune system attacks the body’s nerves. This harm causes muscle weakness and sometimes paralysis.
“This is just malicious. I don’t know how else to say it. The CDC, FDA, WHO – they know this, and yet they’re still promoting this horrible product,” Bigtree said in a recent episode of “The HighWire.”
During the show, co-host Jefferey Jaxen read an article authored by neurological disease expert Michael Lunn about the GBS being associated with the AstraZeneca COVID-19 vaccine.
“At the moment, we don’t know why a vaccine may cause these very small rises in GBS. It may be that a non-specific immune activation in susceptible individuals occurs, but if that were the case, similar risks might apply to all vaccine types,” Lunn said. “It is therefore logical to suggest that the simian adenovirus vector, often used to develop vaccines, including AstraZeneca’s, may account for the increased risk.”
Jaxen shared that between January to October 2021, 996 GBS cases were recorded in the United Kingdom National Immunoglobulin Database.
However, there was an unusual spike in GBS reports occurring in March and April 2021, which coincided with the rollout of AstraZeneca’s COVID-19 vaccine in the United Kingdom. The were about 140 cases recorded per month during that period – a 40 percent increase compared to the historical average of 100 per month.
Even in the U.S., the FDA saw a potential of neurological complication with Johnson and Johnson or the Janssen vaccine, which is another adenovirus vector vaccine like AstraZeneca. (Related: Texas teen develops Guillain-Barre syndrome weeks after receiving first coronavirus vaccine dose.)
“Those are people whose lives were changed forever, some of them in wheelchairs. And they’re not even discontinuing them. They’re doubling down and saying get a third and fourth shot,” Bigtree said.
1976 and 2009 swine flu vaccines have been linked to GBS
At the height of the swine flu scare in 1976, 46 million Americans obediently took the vaccine to prevent the virus from spreading. Now, 4,000 people are claiming damages from the U.S. government amounting to $3.5 billion. Two-thirds of them are for neurological damage.
A “60-minute” episode about the 1976 swine flu included a report about Judy Roberts, a perfectly healthy and active woman before she took the shot in November 1976. Two weeks later, she began to feel a numbness starting up her leg.
“By the following week, I was totally paralyzed,” she said.
The video, which was played during Bigtree’s show, showed that doctors had to operate on Roberts to enable her to breathe. And for six months, she was quadriplegic and was diagnosed with GBS.
“GBS was also associated with the 2009 H1N1 vaccine, when that was pushed,” Jaxen noted. He read a news headline published by CBS News in 2011: “H1N1 flu vaccine tied to higher risk of Guillain-Barre syndrome.”
The article mentioned that researchers discovered that 77 people developed GBS up to 91 days after receiving the swine flu vaccine. The results of the study, which was published by the Lancet in March 2013, were derived from 23 million people in the U.S. who received the H1N1 vaccine and responded to a survey.
Now, the horrors brought by GBS have resurfaced because of COVID-19 vaccines. “It’s just shocking that anyone thinks it would be a good idea to take a total experimental product,” Bigtree said.
Watch the full June 3 episode of “The HighWire” below.
Sources include: 1 / 2 / 3 / 4 / 5 / 6 / 7 / 8
by: Belle Carter
Join: 👉 https://t.me/acnewspatriots
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of AC.NEWS
Disclaimer: This article may contain statements that reflect the opinion of the author. The contents of this article are of sole responsibility of the author(s). AC.News will not be responsible for any inaccurate or incorrect statement in this article www.ac.news websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner. Reprinting this article: Non-commercial use OK. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Discussion about this post